Sands Capital Management
MRTX

Sands Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Sands Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-393,886
Closed -$86.5M – 78
2020
Q4 		$86.5M Sell
393,886
-936,816
-70% -$203M 0.16% 60
2020
Q3 		$221M Sell
1,330,702
-837,870
-39% -$115M 0.48% 48
2020
Q2 		$248M Sell
2,168,572
-79,437
-4% -$7.7M 0.6% 44
2020
Q1 		$173M Buy
2,248,009
+446,269
+25% +$40M 0.58% 42
2019
Q4 		$232M Buy
1,801,740
+470,757
+35% +$45.4M 0.67% 37
2019
Q3 		$104M Sell
1,330,983
-48,631
-4% -$4.56M 0.33% 48
2019
Q2 		$142M Buy
+1,379,614
New +$107M 0.42% 41

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return